When compared to GLP-1 receptor agonists alone, DA-CH5 had greater neuroprotection than exendin-4 [110], whilst DA-CH3 protected dopaminergic neurons, reduced inflammation, and MPTP-induced motor impairment to a greater extent than liraglutide [115]
That flexibility may help simplify treatment for patients managing busy schedules or multiple medications, and may also help support long-term use once weight loss goals are reached
General Information
Prescribing the drugs to treat substance use, at least for now, isn't possible because they aren't approved by the U.S
It is a colorless, odorless, viscous liquid that is sweet-tasting and non-toxic
For readers comparing treatment options, our article on how semaglutide and spironolactone can fit together offers a useful related perspective